XML 48 R37.htm IDEA: XBRL DOCUMENT v3.25.2
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity
   
Year ended December 31,
 
   
2024
   
2023
   
2022
 
                   
Risk free interest
   
3.85%-4.56
%
   
3.57%-4.58
%
   
1.41%-4.15
%
Dividend yields
   
0
%
   
0
%
   
0
%
Volatility
   
47.75%-49.00
%
   
52.77%-53.87
%
   
51.45%-52.95
%
Expected term (in years)
   
3.82-3.83
     
3.85-3.92
     
3.92-4.00
 
Schedule of Stock-Based Compensation Expenses
   
Number of options
   
Weighted-average
exercise price
   
Weighted- average
remaining
contractual term
(in years)
   
Aggregate intrinsic
value
(in thousands)
 
                         
Outstanding as of January 1, 2024
   
5,679,775
   
$
6.9
     
4.2
   
$
817
 
                                 
Granted
   
355,000
   
$
5.6
                 
Exercised
   
(76,875
)
 
$
6.4
                 
Forfeited and cancelled
   
(667,275
)
 
$
9.1
                 
                                 
Outstanding as of December 31, 2024
   
5,290,625
   
$
6.6
     
3.6
   
$
1,060
 
                                 
Exercisable as of December 31, 2024
   
2,203,333
   
$
6.9
     
2.8
   
$
268
 
Schedule of Stock Option Activity by Exercise Price
   
Year ended December 31,
 
   
2024
   
2023
   
2022
 
                   
Cost of revenues of products
 
$
214
   
$
185
   
$
147
 
Cost of revenues of services
   
304
     
222
     
146
 
Research and development expenses, net
   
674
     
654
     
427
 
Selling and marketing expenses
   
611
     
417
     
456
 
General and administrative expenses
   
4,923
     
1,945
     
1,044
 
                         
   
$
6,726
   
$
3,423
   
$
2,220